Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey.
Ocak T, Yağız B, Ocak B, Yoğurtçu Ö, Başıbüyük F, Tezcan D, Ermurat S, İnanç E, Yamancan G, Albayrak F, Sağır RP, Bayındır Akbaş AN, Cüre O, Coşkun BN, Yolbaş S, Karasu U, Kısacık B, Koca SS, Sarı İ, Akar S, Dalkılıç E, Pehlivan Y. Ocak T, et al. Among authors: yagiz b. J Clin Med. 2024 Oct 18;13(20):6216. doi: 10.3390/jcm13206216. J Clin Med. 2024. PMID: 39458166 Free PMC article.
The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience.
Ekin A, Mısırcı S, Coşkun BN, Yağız B, Dalkılıç E, Pehlivan Y. Ekin A, et al. Among authors: yagiz b. Eur Rev Med Pharmacol Sci. 2024 May;28(10):3513-3522. doi: 10.26355/eurrev_202405_36286. Eur Rev Med Pharmacol Sci. 2024. PMID: 38856126 Free article.
60 results